NUTRA PHARMA CORP (NPHC)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Annual

0 500K 1M 1.5M FY10: 1.4M FY11: 159.6K FY12: 203.3K FY13: 104.8K FY14: 594.5K FY15: 291.3K FY16: 168.4K FY17: 121K FY18: 130.6K FY19: 104.4K FY20: 51.9K FY21: 97.7K FY22: 145.8K FY23: 205.6K FY24: 246.3K FY25: 257.6K FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Gross Profit Annual

-900K -600K -300K 0 300K 600K 900K FY10: 815.4K FY11: -720K FY12: 55.6K FY13: 63.7K FY14: 480.2K FY15: 225.5K FY16: -54.6K FY17: 94.1K FY18: 14.1K FY19: 34.7K FY20: 14.9K FY21: 8.5K FY22: 249K FY23: 396.5K FY24: 247.3K FY25: 196.6K FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Operating Income Annual

-6M -4M -2M 0 2M 4M 6M FY10: -3.4M FY11: -4M FY12: -2.6M FY13: -2.4M FY14: -2.2M FY15: -5.8M FY16: -2M FY17: -1.4M FY18: -1.9M FY19: -1.2M FY20: -924.9K FY21: -2M FY22: -1.9M FY23: -887K FY24: -878.4K FY25: -1.5M FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Net Income Annual

-15M -10M -5M 0 5M 10M 15M FY09: -2.3M FY10: -3.1M FY11: -4.4M FY12: -3.6M FY13: -4.3M FY14: -2.5M FY15: -5.4M FY16: -3.4M FY17: -4M FY18: -3.9M FY19: -6.6M FY20: -769.2K FY21: -13.1M FY22: 8.2M FY23: -1.4M FY24: -1.3M FY25: -2M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Cost of Revenue Annual

0 300K 600K 900K FY10: 616.6K FY11: 879.6K FY12: 147.6K FY13: 41.2K FY14: 114.3K FY15: 65.8K FY16: 39K FY17: 26.9K FY18: 68.8K FY21: 41.3K FY22: 162.8K FY23: 177.5K FY24: 84.8K FY25: 183.7K FY11 FY13 FY15 FY17 FY21 FY23 FY25

Operating Cash Flow Annual

-2.1M -1.4M -700K 0 700K 1.4M 2.1M FY10: -1.4M FY11: -1.9M FY12: -721.2K FY13: -531K FY14: -148.1K FY15: -1M FY16: -1.4M FY17: -1.1M FY18: -999.9K FY19: -743.7K FY20: -878.1K FY21: -1.7M FY22: -762.4K FY23: -550K FY24: -424K FY25: -1.2M FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Free Cash Flow Annual

-2.1M -1.4M -700K 0 700K 1.4M 2.1M FY10: -1.4M FY11: -1.9M FY12: -721.2K FY14: -169.7K FY15: -1M FY16: -1.4M FY17: -1.1M FY20: -884K FY21: -1.8M FY22: -820.4K FY25: -1.2M FY10 FY11 FY12 FY14 FY15 FY16 FY17 FY20 FY21 FY22 FY25

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

0 7B 14B 21B FY21: 7.2B FY22: 19.1B FY23: 7.6B FY24: 7.7B FY25: 7.8B FY21 FY22 FY23 FY24 FY25

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-0.15 -0.10 -0.05 0.00 0.05 0.10 0.15 Q4 '10: -0.01 Q1 '11: 0.00 Q2 '11: 0.00 Q3 '11: 0.00 Q4 '11: 0.00 Q1 '12: 0.00 Q2 '12: 0.00 Q3 '12: 0.00 Q4 '12: -0.01 Q1 '13: -0.01 Q2 '13: -0.01 Q3 '13: -0.01 Q4 '13: 0.00 Q1 '14: 0.00 Q2 '14: -0.05 Q3 '14: -0.06 Q4 '14: -0.08 Q1 '15: -0.09 Q2 '15: -0.08 Q3 '15: -0.01 Q4 '15: -0.10 Q1 '16: -0.10 Q2 '16: -0.07 Q3 '16: -0.13 Q4 '16: -0.02 Q1 '17: -0.03 Q2 '17: -0.02 Q3 '17: -0.02 Q4 '17: 0.00 Q1 '18: 0.02 Q2 '18: 0.02 Q3 '18: 0.02 Q4 '18: 0.00 Q1 '19: 0.00 Q2 '19: 0.00 Q3 '19: 0.00 Q4 '19: 0.00 Q1 '20: 0.00 Q2 '20: 0.00 Q3 '20: 0.00 Q4 '20: 0.00 Q1 '21: 0.00 Q2 '21: 0.00 Q3 '21: 0.00 Q4 '21: 0.00 Q1 '22: 0.00 Q2 '22: 0.00 Q3 '22: 0.00 Q4 '22: 0.00 Q1 '23: 0.00 Q2 '23: 0.00 Q3 '23: 0.00 Q4 '23: 0.00 Q1 '24: 0.00 Q2 '24: 0.00 Q3 '24: 0.00 Q4 '24: 0.00 Q1 '25: 0.00 Q2 '25: 0.00 Q3 '25: 0.00 Q4 '25: 0.00 Q1 '26: 0.00 Q2 '26: 0.00 Q2 '12 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.